Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.
UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.
For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.
UBS AG is offering $200,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of NVIDIA Corporation, scheduled to mature on November 24, 2028. These unsecured debt notes pay a contingent coupon only when NVIDIA’s closing share price on a quarterly observation date is at or above a preset coupon barrier; otherwise, no coupon is paid for that period.
The notes are automatically called before maturity if NVIDIA’s stock closes at or above the initial level on an observation date, in which case investors receive the $10 principal per Note plus any due coupon, and the product ends. If the notes are not called and NVIDIA’s final level on the valuation date is at or above the downside threshold, investors receive their full principal back (and a final coupon if the coupon barrier is met). If the final level is below the downside threshold, repayment is reduced in line with the stock’s percentage loss, and investors can lose up to their entire investment.
The notes are not listed on any exchange, and any payment depends on UBS’s credit. The minimum investment is 100 Notes at $10 each, and the estimated initial value is $9.69 per Note, reflecting UBS’s internal pricing and funding costs.
UBS AG is offering $460,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of NVIDIA Corporation, maturing on November 24, 2027. The Notes pay a contingent coupon only if NVIDIA’s share price on each observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period. UBS will automatically call the Notes before maturity if NVIDIA’s share price is at or above the initial level on an observation date, repaying the $10 principal per Note plus any due coupon, with no further payments.
If the Notes are not called and NVIDIA’s final share price on the valuation date is at or above the downside threshold, investors receive back their principal at maturity. If it is below the downside threshold, repayment is reduced in line with the stock’s decline, and the entire investment can be lost. Any payment depends on UBS’s credit; a UBS default could result in a total loss. The minimum investment is 100 Notes ($1,000 total), and the estimated initial value is $9.80 per $10 Note.
UBS AG filed a Form 6-K to update the legal opinion associated with its existing shelf registration statement on Form F-3. The report states that a new Opinion of Homburger AG, acting as special Swiss counsel to UBS, is being filed as Exhibit 5.3 to the Form F-3 and replaces a prior opinion dated August 1, 2025. The Form 6-K is incorporated by reference into the Form F-3 registration statement, keeping the legal documentation for UBS’s registered securities current.
UBS AG is offering $1,250,000 of Step Down Trigger Autocallable Notes, issued in $1,000 denominations and linked to the Solactive U.S. Large Cap Volatility Navigator 40 Index. The notes can be automatically called monthly after 12 months if the index closes at or above a declining call threshold, paying principal plus a call return based on a 13.00% per annum rate; the longer the notes remain outstanding, the higher the call price, up to 65.00% total at the final observation.
If the notes are never called and the index finishes below the 50.00% downside threshold (137.64 versus an initial level of 275.27), repayment at maturity equals $1,000 times (1 + index return), so investors lose one‑for‑one with the index and could lose their entire principal. The notes do not pay coupons or dividends, have no upside participation beyond the call return, are not exchange‑listed, and carry full credit risk of UBS. The estimated initial value is $964.00 per note, below the $1,000 issue price, reflecting fees, hedging costs and UBS’s internal funding rate.
UBS AG is offering Capped Buffer Contingent Absolute Return Securities linked to the S&P 500 Index, with a total issue of $2,100,000 in $1,000 denominations maturing on December 17, 2026. The notes provide upside exposure to the index up to a maximum gain of 15.00%, for a maximum payment of $1,150 per Security if the index rises sufficiently.
If the index return is zero or negative but the final level stays at or above the downside threshold of 6,060.70 (90% of the 6,734.11 initial level), investors receive a contingent positive return equal to the absolute value of the index loss multiplied by the 0.50 downside participation rate, effectively capped at a 5.00% gain, or $1,050. Below the downside threshold, principal is reduced one-for-one beyond the 10% buffer, and investors can lose almost all of their investment.
The Securities pay no interest, do not provide dividends, are not listed on any exchange and may have limited or no secondary market. All payments depend on the creditworthiness of UBS; the estimated initial value is $994.40 per $1,000, reflecting underwriting discounts, hedging and issuance costs.
UBS AG is offering preliminary Trigger Autocallable Contingent Yield Notes linked to the American depositary receipts of Petróleo Brasileiro S.A. The unsecured Notes pay contingent coupons only when the Petrobras ADR closes at or above a specified coupon barrier on an observation date, and they can be called early if the ADR closes at or above the initial level, returning principal plus any due coupon.
If the Notes are not called and the final ADR level is at or above the downside threshold, investors receive the $10 principal amount per Note at maturity; if it is below the downside threshold, repayment is reduced in line with the ADR’s decline and can result in a total loss. The Notes are offered in minimums of 100 Notes at $10 each, are not listed on any exchange, and carry UBS credit risk. The estimated initial value on the trade date is expected to be between $9.15 and $9.40 per $10 Note.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of UnitedHealth Group Incorporated, maturing on or about February 22, 2027. Each Note has a $10 principal amount, with a minimum investment of 100 Notes ($1,000).
Investors receive a contingent coupon on each observation date only if the underlying stock closes at or above a specified coupon barrier; otherwise no coupon is paid for that period. The Notes are automatically called early if the stock closes at or above its initial level on any observation date before maturity, returning principal plus the applicable contingent coupon, with no further payments.
If the Notes are not called and the final stock level is at or above the downside threshold, investors receive back only the principal at maturity. If the final level is below that threshold, repayment of principal is reduced in line with the negative stock return, and investors can lose their entire investment. Any payment depends on the creditworthiness of UBS, the Notes will not be listed on an exchange, and the estimated initial value is expected to be between $9.48 and $9.73 per $10 Note.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Intel Corporation, maturing on or about November 20, 2028. These unsecured debt obligations pay a contingent coupon only if Intel’s closing share price on an observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period.
The Notes are automatically called if, on any monthly observation date starting after three months, Intel’s share price is at or above the initial level, in which case investors receive the principal plus any due contingent coupon and the Notes terminate. If the Notes are not called and Intel’s final share price is at or above the downside threshold at maturity, investors receive their full principal back, plus a final contingent coupon if the coupon barrier is also met.
If the Notes are not called and Intel’s final share price is below the downside threshold, repayment is reduced dollar-for-dollar with Intel’s decline, and investors can lose some or all of their initial investment. All payments, including any contingent coupons and principal repayment, depend on the creditworthiness of UBS. The Notes are offered in minimum denominations of 100 Notes at $10 each, and the estimated initial value is expected to be between $9.48 and $9.73 per Note.
UBS AG is offering unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of UnitedHealth Group Incorporated, maturing on or about November 20, 2028. The Notes pay a contingent coupon only if the stock closes at or above a preset coupon barrier on each observation date; if it is below the barrier, no coupon is paid for that period.
The Notes are automatically called early if, on any quarterly observation date beginning after 6 months, the stock closes at or above its initial level. In that case, investors receive the principal amount plus any due contingent coupon, and the Notes terminate. If the Notes are not called and the final stock level is at or above a downside threshold, investors receive only the principal at maturity; if it is below the threshold, repayment is reduced in line with the stock’s decline, and the entire investment can be lost.
Each Note has a $10 denomination with a minimum investment of 100 Notes, and the estimated initial value per Note on the trade date is expected to be between $9.39 and $9.64. Payments depend entirely on the creditworthiness of UBS, the Notes are not insured by any government agency, and they will not be listed on any securities exchange.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Advanced Micro Devices, Inc., maturing on November 20, 2028. Each Note has a principal amount of
The Notes are automatically called early if AMD’s stock closes at or above the initial level on a quarterly observation date after an initial period, in which case investors receive principal plus any due contingent coupon, and the Notes terminate. If the Notes are not called and AMD’s final stock level is at or above the downside threshold, investors receive full principal at maturity; if it is below, repayment is reduced in line with AMD’s decline and can fall to zero.
Any payment on the Notes depends on UBS’s ability to meet its obligations. The estimated initial value is
FAQ
What is the current stock price of UBS ETRACS Alerian MLP ETN Series B (AMUB)?
